160 related articles for article (PubMed ID: 29243023)
21. Control of Lung Metastases and Colon Polyposis with Lenvatinib Therapy in a Patient with Cribriform-Morular Variant of Papillary Thyroid Carcinoma and an
Ito Y; Ishikawa H; Kihara M; Hirokawa M; Kiyota N; Kasahara T; Miyauchi A
Thyroid; 2019 Oct; 29(10):1511-1517. PubMed ID: 31317827
[No Abstract] [Full Text] [Related]
22. A rare case of the recurrent surgery for cribriform-morular variant of papillary thyroid carcinoma.
Enomoto K; Tamagawa S; Kumashiro N; Warigaya K; Takeda S; Gunduz M; Murata SI; Hotomi M
Int J Surg Case Rep; 2020; 66():385-389. PubMed ID: 31954984
[TBL] [Abstract][Full Text] [Related]
23. Cribriform morular variant of papillary thyroid carcinoma: Cytomorphology, differential diagnosis and diagnostic implications in patients with adenomatous polyposis coli.
Priyani AA; Opatha ST; Gunathilake NW; Lokuhetty MD
J Cytol; 2016; 33(4):235-238. PubMed ID: 28028343
[TBL] [Abstract][Full Text] [Related]
24. Our experience of treatment of cribriform morular variant of papillary thyroid carcinoma; difference in clinicopathological features of FAP-associated and sporadic patients.
Ito Y; Miyauchi A; Ishikawa H; Hirokawa M; Kudo T; Tomoda C; Miya A
Endocr J; 2011; 58(8):685-9. PubMed ID: 21670544
[TBL] [Abstract][Full Text] [Related]
25. Pulmonary metastasis of cribriform-morular variant of thyroid carcinoma mimicking primary adenocarcinoma of the lung: A potential pitfall.
Laforga JB; Pedro T; Gasent JM
Diagn Cytopathol; 2020 Jan; 48(1):78-81. PubMed ID: 31483569
[TBL] [Abstract][Full Text] [Related]
26. Cribriform-morular variant of papillary thyroid carcinoma: clue to early detection of familial adenomatous polyposis-associated colon cancer.
Tomoda C; Miyauchi A; Uruno T; Takamura Y; Ito Y; Miya A; Kobayashi K; Matsuzuka F; Kuma S; Kuma K; Kakudo K
World J Surg; 2004 Sep; 28(9):886-9. PubMed ID: 15593462
[TBL] [Abstract][Full Text] [Related]
27. TERT Promoter Mutation in an Aggressive Cribriform Morular Variant of Papillary Thyroid Carcinoma.
Oh EJ; Lee S; Bae JS; Kim Y; Jeon S; Jung CK
Endocr Pathol; 2017 Mar; 28(1):49-53. PubMed ID: 27688081
[TBL] [Abstract][Full Text] [Related]
28. Familial adenomatous polyposis-associated, cribriform morular variant of papillary thyroid carcinoma harboring a K-RAS mutation: case presentation and review of molecular mechanisms.
Giannelli SM; McPhaul L; Nakamoto J; Gianoukakis AG
Thyroid; 2014 Jul; 24(7):1184-9. PubMed ID: 24702198
[TBL] [Abstract][Full Text] [Related]
29. A distinct variant of papillary thyroid carcinoma indicating familial adenomatous polyposis (FAP): a case report and brief review.
Liyanapathirana N; Seneviratne SA; Samarasekera DN
BMC Res Notes; 2015 Dec; 8():795. PubMed ID: 26681171
[TBL] [Abstract][Full Text] [Related]
30. High expression and localization of β-catenin and epidermal growth factor receptor identify high risk papillary thyroid carcinoma patients.
Išić Denčić T; Bartolome A; Šelemetjev S; Đorić I; Tatić S; Živaljević V; Cvejić D
Exp Mol Pathol; 2018 Oct; 105(2):181-189. PubMed ID: 30077672
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the diagnostic value of emerin and CD56 in papillary thyroid carcinoma - an immunohistochemical study.
Abdou AG; Abdelwahed M; Said A; Taie DM; Fahmy S
J Immunoassay Immunochem; 2018; 39(5):521-537. PubMed ID: 30188764
[TBL] [Abstract][Full Text] [Related]
32. Age- and Gender-Specific Risk of Thyroid Cancer in Patients With Familial Adenomatous Polyposis.
Uchino S; Ishikawa H; Miyauchi A; Hirokawa M; Noguchi S; Ushiama M; Yoshida T; Michikura M; Sugano K; Sakai T
J Clin Endocrinol Metab; 2016 Dec; 101(12):4611-4617. PubMed ID: 27623068
[TBL] [Abstract][Full Text] [Related]
33. Cribriform morular thyroid carcinoma: a case report with pathological, immunohistochemical, and molecular findings suggesting an origin from follicular cells (or their endodermal precursors).
Echegoyen-Silanes A; Pineda-Arribas JJ; Sánchez-Ares M; Cameselle-García S; Sobrino B; Ruíz-Ponte C; Piso-Neira M; Anda E; Cameselle-Teijeiro JM
Virchows Arch; 2023 Mar; 482(3):615-623. PubMed ID: 36689061
[TBL] [Abstract][Full Text] [Related]
34. Cribriform-Morular Variant of Papillary Thyroid Carcinoma With Poorly Differentiated Features: A Case Report With Immunohistochemical and Molecular Genetic Analysis.
Corean J; Furtado LV; Kadri S; Segal JP; Emerson LL
Int J Surg Pathol; 2019 May; 27(3):294-304. PubMed ID: 30176755
[TBL] [Abstract][Full Text] [Related]
35. Cribriform-morular variant of papillary thyroid carcinoma: molecular characterization of a case with neuroendocrine differentiation and aggressive behavior.
Cameselle-Teijeiro J; Menasce LP; Yap BK; Colaco RJ; Castro P; Celestino R; Ruíz-Ponte C; Soares P; Sobrinho-Simões M
Am J Clin Pathol; 2009 Jan; 131(1):134-42. PubMed ID: 19095577
[TBL] [Abstract][Full Text] [Related]
36. Cribriform-morular variant of papillary thyroid carcinoma displaying poorly differentiated features.
Nakazawa T; Celestino R; Machado JC; Cameselle-Teijeiro JM; Vinagre J; Eloy C; Benserai F; Lameche S; Soares P; Sobrinho-Simões M
Int J Surg Pathol; 2013 Aug; 21(4):379-89. PubMed ID: 23349472
[TBL] [Abstract][Full Text] [Related]
37. The diagnostic utility of cytokeratin 19 in differentiating malignant from benign thyroid lesions.
Wa Kammal WS; Yahaya A; Shah SA; Abdullah Suhaimi SN; Mahasin M; Mustangin M; Md Isa N
Malays J Pathol; 2019 Dec; 41(3):293-301. PubMed ID: 31901914
[TBL] [Abstract][Full Text] [Related]
38. Morules in cribriform-morular variant of papillary thyroid carcinoma: Immunohistochemical characteristics and distinction from squamous metaplasia.
Hirokawa M; Kuma S; Miyauchi A; Qian ZR; Nakasono M; Sano T; Kakudo K
APMIS; 2004; 112(4-5):275-82. PubMed ID: 15233643
[TBL] [Abstract][Full Text] [Related]
39. Ubiquitin Immunostaining in Thyroid Neoplasms Marks True Intranuclear Cytoplasmic Pseudoinclusions and May Help Differentiate Papillary Carcinoma from NIFTP.
Cracolici V; Krausz T; Cipriani NA
Head Neck Pathol; 2018 Dec; 12(4):522-528. PubMed ID: 29512025
[TBL] [Abstract][Full Text] [Related]
40. Unique Clinical Significance of the Cribriform-Morular Variant of Papillary Thyroid Carcinoma.
Erickson LA
Mayo Clin Proc; 2020 Apr; 95(4):831-833. PubMed ID: 32247361
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
